pharma

  1. Capital Group sells stake in Mankind Pharma for Rs 385 crore

    New Delhi: Financial services company Capital Group on Wednesday sold stake in Mankind Pharma for Rs 385 crore through an open market transaction.US-based Capital Group sold 18.50 lakh shares or 0.5 per cent stake in Mankind Pharma through its associate Hema CIPEF (I) Ltd, according to block...
  2. Promoters of Sudeep Pharma, India fully acquired 50% shares from JRS Pharma, Germany, regaining 100% ownership.

    Vadodara, India, July 8, 2024 – The promoters of Sudeep Pharma Private Limited have completed the acquisition of shares from their joint venture partners, JRS PHARMA, regaining 100% ownership of the company. This strategic move represents an important step in Sudeep Pharma's continued growth and...
  3. Dr Reddy's, Sun Pharma recall medicines from US market: USFDA

    New Delhi, Dr Reddy's Laboratories and Sun Pharma are recalling products in the US due to manufacturing issues, according to the latest Compliance Report from the US Food and Drug Administration (USFDA).According to the report, Dr Reddy's Laboratories is withdrawing drugs to treat insomnia and...
  4. Sensex hits new all-time high on positive global cues

    At 9:50 am, Sensex was up 370 points or 0.46 per cent at 80,361 and Nifty was up 101 points or 0.42 per cent at 24,392.Among sectoral indices, Auto, IT, Metal, Realty, Energy and Infra are among the major gainers, and Pharma and Healthcare are among the major losers.Tata Motors, ICICI Bank...
  5. GTI Capital Group sells 4.7 percent stake in Samhi Hotels for Rs 193 crore

    New Delhi: Investment firm GTI Capital Group on Friday sold 4.7 per cent stake in hospitality firm Samhi Hotels for Rs 193 crore through an open market transaction.GTI Capital Alpha, a subsidiary of Mauritius-based GTI Capital Group, sold shares of Samhi Hotels through separate block deals on...
  6. Orchid Pharma partners with Cipla to distribute new antibiotics across India

    New Delhi: Orchid Pharma Ltd on Friday said it has partnered with Cipla for the launch and distribution of its new antibiotic Cefepime-Enmetazobactam in India.The company's new drug, Cefepime-Enmetazobactam, has been approved for the treatment of complicated urinary tract infections (UTI)...
  7. Indian pharma exporter: 'US$ 10 billion opportunity in off-patent drug market by 2029'

    Hyderabad, As many as 15 blockbuster drugs whose revenues worth $112 billion will go off-patent between 2023 and 2029 and the Indian pharma industry will have a growth opportunity of $10 billion in the form of generics (including complexes) said a senior official. of the Pharmaceutical Export...
  8. Sensex is trading flat amid selling in midcap stocks.

    At 9:42 am, Sensex was up 49 points or 0.06 per cent at 78,103 and Nifty was at 23,709, down 11 points or 0.05 per cent.Nifty Midcap 100 index fell 75 points or 0.13 per cent to 55,294 and Nifty Smallcap 100 index rose 41 points or 0.23 per cent to 18,284.UltraTech Cement, ICICI Bank, L&T...
  9. Sun Pharma completes merger with Taro

    New Delhi, Sun Pharmaceutical Industries on Monday said it has completed the merger of Taro Pharmaceutical Industries with itself in a deal worth USD 347.73 million.As part of the merger, Sun Pharma has acquired all the outstanding ordinary shares of Taro in addition to the shares already held...
  10. Japan's Takeda allows Sun Pharma, Cipla to market gastro drug in India

    The drug, sold in tablet form under the brand name 'Voltapraz', blocks a key step in the production of acid in the stomach, Sun Pharma said on Friday.Takeda has granted non-exclusive patent licensing rights to the drug to both drug manufacturers.Cipla and Sun Pharma will independently...
  11. Sun Pharma receives USFDA warning letter for Dadra unit

    New Delhi, Sun Pharmaceutical Industries Ltd on Wednesday said it has received a warning letter from the US health regulator for its Dadra facility over violation of manufacturing norms.Sun Pharma said in a regulatory filing that the warning letter from the US Food and Drug Administration...
  12. Promoter Fosun sells 6 percent stake in Gland Pharma for Rs 1,754 crore

    New Delhi: Fosun Pharma, one of the promoters of Gland Pharma, on Wednesday sold 6 per cent stake for Rs 1,754 crore through an open market transaction.Chinese pharmaceutical firm Fosun Pharma through its arm Fosun Pharma Industrial Pte sold shares of Hyderabad-based Gland Pharma through a...
  13. India's pharma exports register double digit growth amid rising demand in US, UK

    India's pharma exports grew by 10.45 percent to touch $2.3 billion in May this year, compared to $2.08 billion in the same month of the last financial year."It is moving in a positive manner and we are optimistic of maintaining a growth of less than 10 per cent," said Ravi Uday Bhaskar...
  14. Lupine appoints Abdelaziz Toumi as CEO of newly formed arm

    New Delhi, Pharma major Lupine Ltd on Monday announced the appointment of Abdelaziz Toumi as the Chief Executive Officer of its newly formed subsidiary Lupine Manufacturing Solutions.Lupine said in a regulatory filing that Toumi is an experienced leader with a blend of scientific and...
  15. Kotak Alternate Asset Managers to invest Rs 1,445 crore to help Matrix Pharma acquire

    MUMBAI: Kotak Alternate Asset Managers Ltd on Tuesday said it has invested Rs 1,445 crore in Matrix Pharma through a combination of debt and equity to help it acquire the pharmaceutical company.According to an official statement, following the acquisition of Vitris' active pharmaceutical...
  16. Schneider Electric launches Ecostructure for Life Sciences segment, driving sustainability in Indian pharma industry

    • Leading the transformation towards Pharma 4.0 by leveraging the power of digital• Building future-ready pharmaceutical production and biotech facilities to accelerate sustainability, flexibility and agility• Using digital technologies to reduce ~70% CO2 emissions • An IoT-enabled solution...
  17. Sensex closed flat amid market fluctuations

    Midcap and smallcap stocks outperformed largecaps. Nifty Midcap closed at 53,666, up 430 points or 0.81 per cent and Nifty Smallcap 100 closed at 17,571, up 96 points or 0.55 per cent.Among sector indices, Auto, IT, PSU Bank, Realty and Energy were the major gainers. Fin Services, FMCG and...
  18. Schneider Electric launches Ecostructure for Life Sciences segment, driving sustainability in Indian pharma industry

    VMPLNew Delhi [India], June 11: Schneider Electric, the global leader in digital transformation of energy management and NextGen automation, has launched Ecostructure for the Life Sciences segment. This cutting-edge software technology aims to accelerate efficiency and decarbonization of the...
  19. Gland Pharma promotes Srinivas Sadu as Executive Chairman, CEO

    New Delhi, Gland Pharma on Friday said it has appointed its current Managing Director and CEO Srinivas Sadu as Executive Chairman and CEO.His appointment is effective from June 10.Sadu took over the role of MD and CEO on April 25, 2019 and has been instrumental in the growth and success of...
  20. Torrent Group's m-cap doubles to $20 billion in one year

    MUMBAI: Diversified Torrent Group on Friday crossed US$20 billion (Rs 1.68 lakh crore) in market capitalisation, almost doubling its market value due to strong growth in businesses spanning from pharma to energy.Torrent Group's m-cap as on 6 June 2023 was US$10.8 billion (Rs 90,230 crore).On...